Atlas FDA

NeuroPace RNS System

FDA premarket approval P100026/S070 · decided 2019-08-01

Approval details

PMA number
P100026
Supplement
S070
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
NeuroPace RNS System
Generic name
Implanted brain stimulator for epilepsy
Applicant
NeuroPace, Inc.
Date received
2019-06-03
Decision date
2019-08-01
Days to decision
59 days
Decision code
APPR
Product code
PFN
Advisory committee
Neurology
Expedited review
No
Location
Mountain View, CA
Statement
Approval for the following protocol changes and associated changes to data collection and informed consent forms:1) Increase the upper limit on the number of subjects that can be implanted per study site;2) Simplify the text to remove references to activities that are not study-specific (i.e. are standard in the management of the RNS System);3) Revise inclusion/exclusion criteria to only include study-specific criteria;4) Add the option of phone appointments for specific follow-up time points; a

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NEUROPACE BURR HOLE COVER (K141368)NeuroPace, Inc.2014-07-11
NEUROPACE BURR HOLE COVER MODEL 8110 (K123163)NeuroPace, Inc.2013-01-18